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The additive prognostic value of perfusion
and functional data assessed by quantitative
gated SPECT in women
Yves G. C. J. America, MD,a Jeroen J. Bax, MD, PhD,a Eric Boersma, MSc, PhD,b
Marcel Stokkel, MD, PhD,c and Ernst E. van der Wall, MD, PhDa
Background. The aim of this study was to assess the prognostic value of technetium-99m
tetrofosmin gated SPECT imaging in women using quantitative gated single photon emission
computed tomography (SPECT) imaging.
Methods. We followed 453 consecutive female patients. Average follow-up was 1.33 years
(max. 2.55). Hard endpoints were cardiac death, acute myocardial infarction, or documented
ventricular fibrillation. Event-free survival curves were obtained. Optimal cutoff values for left
ventricular (LV) volumes, LV ejection fraction (LVEF), and perfusion data to predict outcome
were determined by ROC curve analysis.
Results. A total of 236 patients had an abnormal study, of whom 27 patients experienced
hard events (16 deaths) and 47 patients soft events. For hard events summed stress score (SSS)
and LVEF, and for any cardiac event SSS showed independent incremental prognostic value.
The survival curves were maximally separated when using cutoff values for SSS of ‡22 and
LVEF < 52% (P < 0.001, HR 4.61 and P < 0.001 HR 5.24 for SSS and LVEF resp.), and
SSS ‡ 14 (P < 0.001 HR 3.76) for any cardiac event.
Conclusion. In women, perfusion and functional parameters derived from quantitative
gated technetium-99m tetrofosmin SPECT imaging can adequately be used for cardiac risk
assessment. Using quantitative gated SPECT, female patients with an LVEF < 52% or an
SSS ‡ 22 are at increased risk for subsequent hard events. Furthermore, patients with an
SSS ‡ 14 are at increased risk for any cardiac events. (J Nucl Cardiol 2009;16:10–9)
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INTRODUCTION
Coronary artery disease (CAD) is the major cause of
morbidity and mortality in the western countries.
Increased mortality and reinfarction have been noted in
women after myocardial infarction compared to men.1-3
The large proportion of atypical symptoms, higher
incidence of associated disease (e.g., hypertension,
diabetes mellitus), and the higher age at presentation
may account for the worse outcome.3,4 Appropriate non-
invasive diagnostic testing is important in the early
diagnosis and the risk stratification of women with
suspected CAD. Exercise ECG has a lower diagnostic
and prognostic accuracy in women. It is influenced by
multiple factors, i.e., exercise capacity and hormonal
status.4,5 The increased age at presentation is often
associated with lower exercise capacity and an inability
to attain maximal stress.4,5 Myocardial perfusion imag-
ing provides incremental prognostic information.4
The addition of regional left ventricular (LV)
function parameters by gated single photon emission
computed tomography (SPECT) improved the diagnos-
tic accuracy and prognostic value of perfusion imaging,
whereby LV function parameters have incremental
prognostic value over perfusion data alone.6-10 Previous
studies set normal functional data limits. However, some
problems still have to be solved. First, most data on
prognostic value of the parameters assessed by gated
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SPECT have been obtained in a mixed gender popula-
tion and may not be applicable to women. Women often
have smaller LV volumes. It has been shown that gender
related differences in normal limits exist.11,12 However,
a multicenter phantom study showed a wide range of
results in different standard end-systolic and end-dia-
stolic volume combinations. Moreover, the LV ejection
fraction (LVEF) was overestimated and both the end-
systolic volume (ESV) and end-diastolic volume (EDV)
were underestimated. Especially, this is the case for
small volumes. Cutoff values for LV functional param-
eters should be validated in each center.13
Second, most data on prognostic value of perfusion
analyses by gated SPECT is obtained by a 20-segment
model. However, recent guidelines on cardiac imaging
suggest the use of a 17-segment model. Berman et al14
showed that a 17-segment model provides a more
accurate prognostic categorization of individual patients
with small abnormalities of the distal short axil and
apical portions of the LV.
At present, few data exist on the prognostic value of
gated SPECT in women. In this category of patients,
little data are available on the value of LV function
parameters to potentially improve risk stratification.
Accordingly, the aim of the study was to assess the
incremental prognostic value of technetium-99m tetro-
fosmin (Tc99m) gated SPECT imaging in women.
METHODS
Study Population
We studied 453 consecutive women (median age 62 years
[53 to 70 years, 25th to 75th percentiles]) who underwent rest/
stress technetium-99m tetrofosmin myocardial perfusion gated
SPECT imaging between October 1, 1999, and January 1,
2000, at the Leiden University Medical Center. Patients were
followed up until the fixed census date May 1, 2000.
Stress Myocardial Perfusion Protocol
All patients were instructed to refrain from caffeine-
containing products for 24 hours before the test. Beta-blocking
agents, nitrates, calcium antagonists were discontinued at least
48 hours prior to SPECT imaging. A symptom-limited bicycle
exercise stress test was performed. Technetium-99m tetrofos-
min (GE, Amersham, UK) was injected at peak stress, and
exercise was continued for an additional 60 seconds. The
exercise stress protocol includes a stepwise increase in work-
load depending on gender, age, weight, and height. This
protocol is routinely applied in our institution. When the
prespecified maximum workload (depending on gender, age,
weight, and height) is achieved, the physical validity is
considered to be at least 100%. Exercise stress endpoints
were severe angina, physical exhaustion, dyspnea, sustained
tachy-arrhythmias, exertional hypotension, or ischemic ST-T
segment-depression of at least 0.2 mV and a duration of
80 milliseconds. Exercise was considered inadequate if the
physical validity of the patient was less than 80% of the pre-
dicted validity (workload) in the absence of angina or an
ischemic ST-depression. Patients who were unable to perform a
physical stress test or patients with a left bundle branch block
underwent a pharmacological stress test as described previ-
ously.15 Vasodilatation was induced using intravenous
administration of adenosine at a dose rate of 0.14 mg/kg/min
for 6 minutes. Technetium-99m tetrofosmin was injected
3 minutes after start of infusion of the pharmacological agent.
Dobutamine 0.3 mg/kg infusion during 15 minutes was used in
patients who were not able to exercise adequately and in whom
the use of adenosine was contraindicated (except patients with
LBBB). Horizontal or downsloping ST-segment depression of
1 mm or greater or upsloping of 1.5 mm or greater at 80 mil-
liseconds after J point was considered positive for ischemia. In
case of ST-T-segment abnormalities, registration of the stress
ECG was continued until normalization of the ECG was seen.
Gated SPECT Acquisition Protocol
Both 1-day and 2-day imaging protocols were used.15 A
dose of 500 MBq technetium-99m tetrofosmin was given
intravenously for the 2-day protocol stress study and 750 MBq
for the 1-day protocol stress study. Dosages of 500 and
250 MBq, respectively, were given for the rest study. All
acquisitions took place 30 to 45 minutes (stress) or 45 to
60 minutes (rest) post-injection. Gated SPECT acquisition
protocol was performed post-stress. In case of 1-day protocol
the rest study was done first. Imaging was performed with a
triple-head 360 rotating gamma camera (Toshiba GC-9300
GMS, Japan). A total of 90 frames of 30’’ duration using a
64 9 64 pixel matrix were obtained at 4-degree intervals using
a non-circular orbit. Sixteen bins per cardiac cycle were
acquired. All studies were pre-filtered using a 9-order Butter-
worth filter at a cutoff frequency of 0.32 cycles/pixel (rest)
[pixel size 6 mm] or 0.26 cycles/pixel (stress). All images
were subject to quality control measures, including cinematic
display for assessment of patient motion, corrections for field
non-uniformity, and center of rotation. No attenuation or
scatter correction was used. The reconstructed data were pro-
jected as tomographic slices in short-axis and vertical/
horizontal long-axis views. Myocardial perfusion data and
quantitative LV volumes and LVEF were calculated using the
commercially available Cedars-Sinai’s Quantitative gated
SPECT (QGS) software, version 2.0, revision A’’.7,8 When
automatic reconstruction or reorientation failed, reconstruction
limits and axes were assigned manually. End-systolic volume
index (ESVi) and EDV index (EDVi), in milliliters per square
meter, were derived by dividing ESV and EDV by body sur-
face area (BSA), respectively.
Semi-Quantitative Visual Analysis
of Myocardial Perfusion SPECT
Semi-quantitative visual interpretation of SPECT perfu-
sion images used short-axis and vertical long-axis tomograms
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divided into 17 segments for each patient.14 These segments
were assigned to four evenly spaced regions in apical, six mid-
ventricular, and six basal slices of the short-axis views and one
apical segment on the mid-ventricular vertical long-axis slice.
Each segment was scored using a five-point scoring system
(0 = normal, 1 = equivocal, 2 = moderate, 3 = severe
reduction of radioisotope uptake, 4 = absence of detectable
radiotracer in a segment). Apparent perfusion defects pre-
sumably caused by soft tissue attenuation were assigned a
score of 1. The observers were blinded to the patient’s clinical
history and results of stress testing.
Three global perfusion indices were employed to combine
assessments of defect extent and severity,16 namely summed
stress score (SSS), summed rest score (SRS), and summed
difference score (SDS). These indices were converted to a
percentage of the total myocardium involved with ischemic, or
fixed defects.17,18 All studies were evaluated by two experi-
enced observers in consensus readings.
Patient Follow-up and Endpoint Definitions
Both medical records and the automated hospital infor-
mation system were reviewed. If these data did not cover the
entire period from recruitment until census date, the patient
was sent a questionnaire. In case of no response, a second
questionnaire was sent after 3 months. Cardiac death (CD) was
noted as death due to any cardiovascular cause, confirmed by
certificate and hospital chart of physician’s records; in addi-
tion, hard events were defined as cardiac death, nonfatal
myocardial infarction (MI), or documented ventricular fibril-
lation. An acute MI was documented by appropriate ECG
findings, accompanied with serum cardiac enzyme level
changes or isolated cardiac enzyme level changes. The cardiac
enzymes used were creatine kinase (CK) and troponin T. Soft
events were defined as any late ([60 days after MPI) revas-
cularization procedure, i.e., coronary artery bypass grafting
(CABG) or percutaneous transluminal coronary angioplasty
(PTCA).
Statistical Analysis
Most continuous variables had non-normal distribution
(as evaluated by Kolmogorov-Smirnov tests). For reasons of
uniformity, summary statistics for all continuous variables are
therefore presented as medians together with the 25th and 75th
percentiles. Categorical data are summarized as frequencies
and percentages. Differences in baseline characteristics
between patients who reached the primary endpoint and those
who did not were analyzed using Wilcoxon-Mann-Whitney
tests, Chi-square tests, or Fisher’s exact tests, as appropriate.
Univariable and multivariable Cox proportional hazard
regression analyses were applied to study the relation between
perfusion and functional data (based on gated SPECT imaging)
and the incidence of study endpoints over time. We considered
a broad range of potential confounders of these relations,
including age, smoking, family history of CAD, hypertension,
diabetes, hyperlipidemia, established CAD, resting heart rate,
type of stressor (pharmacological or exercise), level of
exercise, presenting symptom (angina pectoris), presence of
ischemia on the exercise ECG. Cox models aiming at predic-
tion should be used with a minimum of 10 events per predictor
variable (EPV). Simulation studies showed increasing bias and
variability, unreliable confidence interval coverage, and prob-
lems with model convergence as EPV declined below 10.19,20
However, Vittinghoff and McCulloch demonstrated that this
rule of thumb is too conservative in analyses of causal influ-
ences based on observational data, and control of confounding
may require adjustment for more covariates than the rule of 10
EPV allows.21 Discounting of statistically significant associa-
tions from models that are based on 5 to 9 EPV and that aim to
adjust for confounding is not justified. Hence, multivariable
models that are based on our dataset (with 27 events) could
safely contain 3 to 5 variables. We performed stepwise
regression according to the backward deletion approach,
applying a P-value of 0.15 as threshold for variable removal, to
adjust for as many covariables as is reasonably allowed by the
(limited) number of events. We report crude and adjusted
hazard ratios (HR) and corresponding 95% confidence inter-
vals (CI).
It was not our intention to formally build an outcome
prediction model. Still, all the continuous variables were
assessed for linearity by entering a transformed variable in
addition to the variable of interest. The natural logarithm and
square transformations were used. A significant change in the
-2 log-likelihood was considered as a sign of non-linearity,
otherwise the linearity assumption was accepted. All variables
met the linearity assumption. To check the proportional hazard
assumption, i.e., that the hazard ratio for two subjects with
fixed predictors is constant over time, log(-log[survival prob-
ability]) for different categories was plotted against time to
ensure that the curves were reasonably parallel. In general, all
proportionality assumptions were appropriate.
It appears that SSS and LVEF were associated with the
incidence of study endpoints over time. We applied receiver
operator characteristic (ROC) curve analyses to determine the
optimal cutoff values for these variables that can be used for
event prediction in clinical practice. Optimal cutoff values
were defined as values resulting in the maximal sum of sen-
sitivity and specificity. Subsequently, event-free survival
curves were obtained according to the method of Kaplan and
Meier, separating patients with a value below or above the
threshold. Differences in event-free survival between patients
were evaluated by log-rank tests.
For all analyses, a P value \0.05 was considered statis-




Four-hundred and fifty-three patients were fol-
lowed. The patient baseline characteristics are shown in
Table 1. Median age was 62 (53 to 70 years [25th to
75th percentiles]). One-hundred and fourteen (26%)
patients had known CAD. Of those patients 67 (15%)
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had sustained a MI, 67 (15%) experienced one or more
revascularization procedures, and none had a history of
cardiac arrest.
Perfusion and Function
Perfusion and function data are shown in Table 2.
Two-hundred and thirty-five patients (48%) had an
abnormal perfusion study. Of those, 105 patients (45 %)
showed an ischemic perfusion study. The median SSS
was 5 (25th to 75th percentiles: 0 to 22), the median SRS
was 3 (25th to 75th percentiles: 0 to 17), and the median
SDS was 2 (25th to 75th percentiles: 0 to 3); median
EDV was 70 mL (25th to 75th percentiles: 56 to
89.5 mL), median ESV 24 mL (25th to 75th percentiles:
16 to 39.5 mL), and median LVEF 65.5% (25th to 75th
percentiles: 54% to 73%). The median EDVi was 38
(25th to 75th percentiles: 32 to 49) and the median ESVi
13 (25th to 75th percentiles: 9 to 22).
Outcome
In 422 patients (93.2%) follow-up was complete
until census or death. The average follow-up was
1.33 years (maximum 2.55 years). Twenty-seven
patients suffered a hard event during follow-up, on
average after 1.06 years (range 1 day to 2.50 years).
Sixteen patients died of cardiac cause during follow-up,
with a mean follow-up of 0.72 years (range 1 day to
2.22 years). No hard events occurred during surgery or
coronary intervention. Forty-seven soft events were
recorded (mean follow-up 1.43 years; range 93 days to
2.52 years): 15 patients underwent coronary bypass
surgery, and in 32 patients PTCA was performed.
Patients with hard events during follow-up had
significant larger LV volumes, larger perfusion defects
and lower LVEF than those without hard events.
Patients with any cardiac event during follow-up had
significantly larger LV volumes, more extensive perfu-
sion defects, lower LVEFs, and larger reversible defects
than those without (Table 3).
Results based on univariate analysis are listed in
Table 4. Summed stress score, SRS, all the function
variables (EDV, ESV, EDVi, ESVi, and LVEF) were
predictive for CD and hard events. For hard events
diabetes, smoking, presenting symptom (angina pecto-
ris), and pharmacological stress test were also predictive.
Age, diabetes, hyperlipedemia, smoking, history of MI,
presenting symptom, pharmacological stress test, level
of exercise, and resting heart rate were predictive for any
cardiac event. Also, larger LV volumes (EDV and ESV),
decreased LVEF, larger perfusion defects, and ischemia
were predictive for any cardiac event.
The variables entered in the initial multivariable
model for hard events included age, diabetes, hyper-
tension, family history, hyperlipedemia, smoking,
presenting symptom, history of CAD, history of MI,
history of revascularization, pharmacological stress test,
level of exercise, SSS, SRS, and all the function vari-
ables (EDV, ESV, EDVi, ESVi, and LVEF). For any
cardiac events age, diabetes, hypertension, family his-
tory, hyperlipedemia, smoking, presenting symptom,
known CAD, history of MI, history of revascularization,
pharmacological stress test, resting heart rate, level of
exercise, ischemia on stress ECG, SSS, SRS, and all the
function variables (EDV, ESV, EDVi, ESVi, and LVEF)
were entered in the model.
Table 1. Patient characteristics
Total number of patients 453
Age (years)* 62 (53–70)
Risk factors for CAD





Body Mass Index* 26.9 (26.1–28.8)
Body Mass Area (m2)* 1.8 (1.7–2.5)
History CAD 114 (26%)
Myocardial infarction 67 (15%)
Revascularization 67 (15%)
*Median (25th–75th percentiles).
CABG, Coronary artery bypass graft surgery; CAD, coronary
artery disease.
Body Mass Index according to the Mosteller Formula.




Total patient group (n = 453)
Myocardial perfusion
SSS 5 0–22 0–67
SRS 3 0–17 0–65
SDS 2 0–3 0–34
Left ventricular function
EDV (ml) 70 56–89.5 32–343
ESV (ml) 24 16–39.5 4–298
LVEF (%) 65.5 54–73 13–91
ESVi 13 9–22 2.0–156
EDVi 38 32–49 18–180
SSS, Summed stress score; SRS, summed rest score; SDS,
summed difference score; EDV, end-diastolic volume; ESV,
end-systolic volume; LVEF, left ventricular ejection fraction;
ESVi, end-systolic volume index; EDVi, end-diastolic volume
index.
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Multivariate analysis showed that summed stress
score and LVEF provided independent and incremental
prognostic value for hard events (beyond clinical data
and/or perfusion variables, respectively). Summed stress
score provided independent and incremental prognostic
value for any cardiac event (Table 4).
Survival
The annual CD rate as function of percent stress
defect for \5, 10 to 20, and [20% hypoperfused myo-
cardium was \0.7, 1.6, and 4.6%/years, respectively.
The annual hard event rate for these subgroups are 1.0,
3.1, and 8.3%/year, respectively. ROC curve analysis
was used to determine the optimal cutoff values for
LVEF and SSS to predict outcome. For hard events
optimal cutoff values for these different parameters
could be determined. According to these cutoff values,







SSS 25 (0–46) 4 (0–21) \0.01
SRS 18 (2–30) 2 (0–15) \0.01
Myocardial function
EDV 85 (70–164) 69 (56–87) \0.01
ESV 45 (23–91) 23 (16–37) \0.01
LVEF 50 (31–64) 66 (55–73) \0.01
ESVi 24 (12–49) 12 (8–21) \0.01






SSS 23 (4–35) 3 (0–19) \0.01
SRS 12 (2–24) 1 (0–14) \0.01
SDS 3 (0–13) 0 (0–1) \0.01
Myocardial function
EDV 77 (66–103) 68 (56–86) 0.01
ESV 34 (21–58) 22 (15–37) \0.01
ESVi 17 (10–33) 12 (8–21) \0.01
EDVi 42 (34–59) 38 (32–47) 0.01
LVEF 56 (44–68) 66 (56–73) \0.01
*Values of the median (25th to 75th percentile).
Only parameters that showed significantly differences
between the patient groups are mentioned.
SSS, Summed stress score; SRS, summed rest score; SDS,
summed difference score; EDV, end-diastolic volume; ESV,
end-systolic volume; LVEF, left ventricular ejection fraction;
ESVi, end-systolic volume index; EDVi, end-diastolic volume
index.
Table 4. Univariate and multivariate analysis of
clinical data, perfusion, and functional data
assessed by gated SPECT
Hazard
ratio 95% CI P-value
Univariate analysis
Total mortality
Age 1.02 0.97–1.06 NS
Diabetes 2.58 0.75–8.80 NS
Hypertension 2.08 0.56–7.69 NS
Family history 0.79 0.22–2.79 NS
Lipid 0.39 0.12–1.22 NS
Smoke 1.23 0.55–2.75 NS
CAD 0.95 0.31–2.93 NS
Symptom (AP) 0.99 0.79–1.24 NS
History MI 1.93 0.62–6.00 NS
History revasc 0.00 0.00–0.00 NS
Pharmacological 1.37 0.97–1.93 NS




ECG ischemia 0.72 0.04–1.89 NS
SSS 1.04 1.01–1.07 0.01
SRS 1.04 1.01–1.07 0.01
SDS 1.05 0.98–1.13 NS
EDV (mL) 1.01 1.00–1.07 \0.001
ESV (mL) 1.01 1.01–1.02 \0.001
LVEF (%) 0.95 0.92–0.97 \0.001
EDVi 1.03 1.01–1.04 \0.001
ESVi 1.03 1.02–1.04 \0.001
Hard events
Age 1.02 0.98–1.05 NS
Diabetes 3.04 1.24–7.44 0.02
Hypertension 0.91 0.40–2.11 NS
Family history 0.70 0.28–1.72 NS
Lipid 0.76 0.32–1.80 NS
Smoke 1.80 1.02–3.15 0.04
CAD 1.51 0.67–3.40 NS
Symptom (AP) 1.14 1.02–1.27 0.02
History MI 2.14 0.90–5.08 NS
History revasc 0.94 0.51–1.73 NS




Resting HR 0.99 0.96–1.02 NS
ECG ischemia 1.32 0.54–3.24 NS
SSS 1.05 1.03–1.07 \0.001
SRS 1.05 1.03–1.08 \0.001
SDS 1.05 0.99–1.11 NS
EDV (mL) 1.01 1.01–1.02 \0.001
ESV (mL) 1.01 1.01–1.02 \0.001
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patients could be divided into two groups (Figures 1 and
2). An LVEF \ 52% (area under the curve [AUC] 0.75)
was associated with a significantly higher risk of hard
events (P \ 0.0001). Patients with an LVEF \ 52% had
an annual event rate of 11.6% with an annual CD rate of
6.6%, whereas those with an LVEF C 52% had an
annual hard event rate of 1.7%, and an annual CD rate of
0.6%. For SSS, maximal separation could be found
using a cutoff score of 22 (AUC 0.84; P = 0.0001). The
annual hard event rate for patients with an SSS C 22
was 10.5%, whereas those with an SSS \ 22 had an
annual hard event rate of 2.5%.
For any cardiac event optimal cutoff value for SSS
could be determined (Figure 3). Maximal separation
could be found using a cutoff score of 14 (AUC 0.81).
The annual any cardiac event rate for patients with an
SSS C 14 was 20.8%, whereas those with an SSS \ 14




ratio 95% CI P-value
LVEF (%) 0.95 0.93–0.97 \0.001
EDVi 1.02 1.01–1.03 \0.001
ESVi 1.02 1.01–1.03 \0.001
Any cardiac events
Age 1.03 1.01–1.05 0.01
Diabetes 1.88 1.07–3.30 0.03
Hypertension 1.00 0.59–1.67 NS
Family history 1.21 0.69–2.11 NS
Lipid 2.03 1.13–3.64 0.02
Smoke 1.76 1.27–2.45 0.001
CAD 2.27 1.37–3.75 0.001
Symptom (AP) 1.11 1.04–1.20 0.004
History MI 2.36 1.35–4.12 0.003
History revasc 1.09 0.80–1.50 NS
Pharmacological 1.82 1.10–3.00 0.02




ECG ischemia 1.42 0.81–2.48 NS
SSS 1.05 1.03–1.06 \0.001
SRS 1.03 1.02–1.05 \0.001
SDS 1.11 1.08–1.14 \0.001
EDV (mL) 1.01 1.00–1.01 0.01
ESV (mL) 1.01 1.00–1.01 0.01
LVEF (%) 0.98 0.96–0.99 \0.001
EDVi 1.01 1.00–1.02 0.02
ESVi 1.01 1.00–1.02 0.01
Multivariate analysis
Hard events
LVEF (%) 0.97 0.94–1.00 0.03
SSS 1.03 1.01–1.06 0.02
Any cardiac events
SSS 1.06 1.03–1.08 \0.001
Hard events: myocardial infarction, cardiac arrest, ventricular
fibrillation and total mortality; Any cardiac event: myocardial
infarction, cardiac arrest, ventricular fibrillation and total
mortality, revascularization procedure; Symptom (AP):
angina pectoris as presenting symptom; Pharmacological:
pharmacological stress test; Resting HR: resting heart rate;
Level of exercise: % of the target level of exercise adjusted
for gender, age, length and weight; ECG ischemia: ischemia
on stress ECG.
EDV, End-diastolic volume; ESV, end-systolic volume; ESVi,
end-systolic volume index; EDVi, end-diastolic volume index;
LVEF, left ventricular ejection fraction; SSS, Summed stress
score; SRS, summed rest score; SDS, summed difference
score; CAD, coronary artery disease; CI, confidence interval;
MI, myocardial infarction.
Figure 1. Hard endpoints according to the cutoff values for
LVEF.
Figure 2. Hard endpoints according to the cutoff values for
SSS.
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DISCUSSION
Our results show that relatively young female
patients with hard events had significantly larger LV
volumes, increased defect sizes, and lower LVEFs than
those without hard events. Also, patients with any car-
diac event during follow-up had significantly larger LV
volumes, increased defect sizes, and lower LVEFs than
those without any cardiac events. Moreover, patients
with any cardiac event had significantly larger ischemic
defects. For hard events and cardiac death SSS, SRS,
and all the function variables (EDV, ESV, EDVi, ESVi,
and LVEF) were predictive. For hard events diabetes,
smoking, presenting symptom, and pharmacological
stress test were also predictive. Age, diabetes, hyperl-
ipedemia, smoking, history of MI, presenting symptom,
resting heart rate, and pharmacological stress test were
predictive for any cardiac event. Also, larger LV vol-
umes (EDV and ESV), decreased LVEF, larger
perfusion defects, and ischemia were predictive for any
cardiac event. Summed stress score obtained by quan-
titative gated SPECT imaging had independent and
incremental prognostic value for both hard events and
any cardiac event in female patients beyond clinical
data. For hard events also LVEF had independent and
incremental prognostic value beyond clinical and per-
fusion data. Using these perfusion and functional data,
female patients with increased risk of having subsequent
serious cardiac events could be identified. Using ROC
curve analysis, cutoff values for LVEF of 52% and SSS
22 for hard events and SSS of 14 for any cardiac event
yielded the highest sensitivity/specificity (discriminative
power) to predict increased cardiac risk. An SSS [ 22
and an LVEF of \52% were predictive for subsequent
hard events. An SSS [ 14 was predictive for any cardiac
event.
To our knowledge, this is the first study to show that
large ischemic and mixed defects are not all at high risk
of events. Only a combination of perfusion and function
allows to effectively risk stratify this population and
give an individualized risk estimates for this heteroge-
neous population. Therefore, perfusion data per se are
definitely not enough to make individualized prognostic
statements.
Prognostic Value of Perfusion Data
Our perfusion data extend previous findings that
average defect size was largest in those patients who
suffered a hard event. In particular the SSS has been
shown to be a powerful independent predictor of cardiac
events.10,22-24
However, most of the observations have been made
in a mixed gender population.10,22-24 Sharir et al11
showed that for CD and MI, perfusion data provided a
larger proportion of the prognostic information for
women than they did for men. We demonstrated that
perfusion data have incremental value over clinical data,
both for hard events and any cardiac event. In particular,
women with moderate to severe perfusion defects had a
high annual hard event rate. Those with a normal per-
fusion image have very low annual event rate. Stress-
induced ischemia was predictive in women who suffered
any cardiac event but had no incremental prognostic
value for predicting hard events. This is in line with
previous findings that suggest that the extent of defect
size and functional abnormalities are more predictive for
hard events (CD and MI), whereas the extent of ische-
mia is more predictive for soft events and/or MI.10,25-27
By using gated SPECT perfusion imaging, women at
increased risk of having a cardiac event could be
identified.
Most of the published data used a 20-segment
approach. Berman et al14 showed that in a 17-segment
approach the apex and adjacent short-axis slice of the
LV is less overweighed. There was a trend toward less
frequent borderline scans with more normal and severely
abnormal scans in the overall population. They found in
the patients who shifted from abnormal scan by 20-
segment model to normal scan in the 17-segment
approach an equal cardiac death rate to other normal
patients.
Berman et al14 found a significantly higher annual
CD rate for women compared to men in group of
patients with moderately to severe perfusion defects. We
found the same annual CD rates for the patients with
normal images (stress defect \5% of the myocardium,
0.5% vs\0.7%). However, a smaller annual CD rate in
Figure 3. Any cardiac endpoint according to the cutoff values
for SSS.
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the group of patients with severe perfusion defects
(4.6% vs 6.4%) was found. This may be explained by
the fact that our population was 10 years younger. In a
matched aged group, Groutars et al24 found similar
event rates compared to our study (0.4% vs 0.7% annual
CD rate for normal perfusion, 2.1% vs 2.4% annual CD
for moderate to severely abnormal images). Similar
results were found for hard cardiac events. Our optimal
cutoff value to identify patients at high risk for hard
events was 22 (32% of the left ventricle). Patients with a
SSS \ 22 had the same annual hard event rate demon-
strated by Zellweger et al28 for mildly abnormal scans
(2.5% vs 2.4%). Travin et al10 reported similar annual
hard event rates for patients with mildly abnormal per-
fusion images compared to patients with an SSS \ 22 in
our study (2.5% vs 3.0%). The cutoff value of SSS [ 22
suggests that the major part of the hard events occurs in
patients with very large perfusion defects. Therefore, the
group of female patients with severe perfusion defects is
diverse with different outcomes. In our group, using our
cutoff values, it is possible to identify females at
increased risk.
A few data are reported on any cardiac events.
Groutars et al29 reported good outcome in patients with
normal perfusion studies. The annual event rate was
0.8% for any cardiac events. Schinkel et al30 found that
for all cardiac events an abnormal scan and SSS had
independent prognostic value, which is in line with our
results.
Prognostic Value of Functional Data
Our data showed that functional data obtained from
technetium-99m tetrofosmin gated SPECT were pre-
dictive for cardiac events.
We found that patients who suffered a cardiac event
(for subgroups: cardiac death, hard events, and any
cardiac event) during follow-up had significantly
increased LV volumes and a significantly lower LVEF.
Only for hard events functional data (LVEF) had inde-
pendent incremental prognostic value. Our results
underscore previously published data on the prognostic
value of gated SPECT imaging.26-34
Sharir et al9 showed that perfusion variables and
ESV were powerful markers in the prediction of total
coronary events, whereas in the prediction of CD, post-
stress LVEF and ESV were independent predictors and
had incremental value over perfusion data. According to
their criteria, patients were at increased cardiac risk
when they had an LVEF \ 45% and an ESV [ 70 mL.
The study by Sharir et al9 was performed in a very large
cohort of more than 1,600 patients, representing a het-
erogeneous population of patients with CAD in terms of
LV function abnormalities.
Recently, Sharir et al11 showed lower limits of
LVEF in women and men with a low likelihood of
CAD—51% (mean-2 SDs) and 43%, respectively. They
also report upper limits for ESVi and EDVi for both
genders (27 and 60 mL/m2 for women and 39 and
75 mL/m2 in men, respectively).
Compared to the data reported by Sharir et al,9 the
annual event rate in our group of women with an
LVEF C 52% was similar to the annual event rate of a
mixed population of patients with an LVEF C 45%
(regardless of the degree of perfusion abnormality).
To summarize, functional data obtained from tech-
netium-99m tetrofosmin gated SPECT can be used to
identify women at increased cardiac risk. The cutoff
value for LVEF used in a mixed gender population is not
applicable to studies in women. Women at increased risk
of major adverse cardiac events, those with an
LVEF \ 52% and/or an SSS of [22, may benefit from
more aggressive invasive therapy. However, further
randomized prospective studies are needed to show better
clinical outcome of aggressive therapy in these patients.
Study Limitations
It is known that in patients with small hearts, LV
volumes, especially ESV, measured by the QGS tech-
nique, are often underestimated and LVEF is often
overestimated. In general, this phenomenon occurs more
in women than in men because women tend to have
smaller LVs. However, previous studies11 showed a
significant correlation between ESV and EDV vs BSA.
Another study13 showed a systematic underestimation of
volumes, more so for small volumes. As long as the
QGS technique has a high reproducibility (for each
individual center)7,8,35 the data on LV function can be
used for risk stratification.
It would have been interesting to demonstrate
whether LV volumes add prognostic information over
LVEF. However, both variables are strongly interre-
lated, implying that LV volumes and LVEF cannot
simultaneously be incorporated in a statistical model.
Consequently, based on our data it is virtually impos-
sible to decide whether LV volumes add incremental
value to LVEF.
In the present study, we included all female patients
who underwent a myocardial perfusion study, without
screening patients for pre-test likelihood of CAD.
However, according to the used ESC guidelines, most
patients have an intermediate likelihood of CAD. In the
present study, ischemia did not show independent
incremental prognostic value for predicting any cardiac
events, but the study population was relatively small, the
follow-up period was rather short and not for 100%
complete (a total of \5% lost to follow up), and the
Journal of Nuclear Cardiology America et al 17
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number of events was low. Future studies will be needed
to further separate the group of patients with combined
perfusion and functional high risk features.
CONCLUSION
In women, perfusion and functional parameters
derived from quantitative gated technetium-99m tetro-
fosmin SPECT imaging can adequately be used for
cardiac risk assessment. Using quantitative gated
SPECT, female patients with an LVEF \ 52% or an
SSS C 22 are at increased risk for subsequent hard
events. Women with an SSS C 14 are at increased risk
for any cardiac events.
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